Molecule Information
General Information of the Molecule (ID: Mol01007)
Name |
MsrC (MSRC)
,Enterococcus faecium
|
||||
---|---|---|---|---|---|
Synonyms |
msrC; Fragment
Click to Show/Hide
|
||||
Molecule Type |
Protein
|
||||
Gene Name |
msrC
|
||||
Sequence |
FWHQLELSIDSLRVYQQDRIGIIGENGVGKSTLLKLIAGELFPDHGKIQTEITFNYLPQL
TYLAEAKDLNLELASHFQLRLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLD RKSIDRLIEELRYYYGTLVFVSHDRYFLDELATKIWEVKDGEIREFSGNYSAYLTQKELE KKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQK AIQKNAKTLERKLQKIGETTKPQQMKQIRFPVPKSLELHSRYPIMGQNVQLERSGRTLLV NGDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESV IRFVMRQTEFSESLVRSLLNHLGFAQETLAKPLCTLSGGEATRLTIALLFTKPSNVLLLD EPTNFIDMATIEALEKLMQIYPGTILFTSHDSYFVERTADEV Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
4 drug(s) in total
Erythromycin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Resistant Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Resistant Drug | Erythromycin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | The complete sequence (1,479 nucleotides) of msrC, part of which was recently reported by others using a different strain, was determined. This gene was found in 233 of 233 isolates of Enterococcus faecium but in none of 265 other enterococci. Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. This endogenous, species-specific gene of E. faecium is 53% identical to msr(A), suggesting that it may be a remote progenitor of the acquired macrolide resistance gene found in some isolates of staphylococci. |
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Sensitive Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Sensitive Drug | Erythromycin | |||
Molecule Alteration | Truncated mutantion | Disruption (nt 1251 to 1879) |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. |
Macrolides
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Resistant Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Resistant Drug | Macrolides | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | The complete sequence (1,479 nucleotides) of msrC, part of which was recently reported by others using a different strain, was determined. This gene was found in 233 of 233 isolates of Enterococcus faecium but in none of 265 other enterococci. Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. This endogenous, species-specific gene of E. faecium is 53% identical to msr(A), suggesting that it may be a remote progenitor of the acquired macrolide resistance gene found in some isolates of staphylococci. |
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Sensitive Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Sensitive Drug | Macrolides | |||
Molecule Alteration | Truncated mutantion | Disruption (nt 1251 to 1879) |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. |
Quinupristin
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Resistant Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Resistant Drug | Quinupristin | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | The complete sequence (1,479 nucleotides) of msrC, part of which was recently reported by others using a different strain, was determined. This gene was found in 233 of 233 isolates of Enterococcus faecium but in none of 265 other enterococci. Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. This endogenous, species-specific gene of E. faecium is 53% identical to msr(A), suggesting that it may be a remote progenitor of the acquired macrolide resistance gene found in some isolates of staphylococci. |
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Sensitive Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Sensitive Drug | Quinupristin | |||
Molecule Alteration | Truncated mutantion | Disruption (nt 1251 to 1879) |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. |
Zithromax
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Resistant Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Resistant Drug | Zithromax | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | The complete sequence (1,479 nucleotides) of msrC, part of which was recently reported by others using a different strain, was determined. This gene was found in 233 of 233 isolates of Enterococcus faecium but in none of 265 other enterococci. Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. This endogenous, species-specific gene of E. faecium is 53% identical to msr(A), suggesting that it may be a remote progenitor of the acquired macrolide resistance gene found in some isolates of staphylococci. |
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Enterococcus faecium meningitis | [1] | |||
Sensitive Disease | Enterococcus faecium meningitis [ICD-11: 1D01.2] | |||
Sensitive Drug | Zithromax | |||
Molecule Alteration | Truncated mutantion | Disruption (nt 1251 to 1879) |
||
Experimental Note | Identified from the Human Clinical Data | |||
In Vitro Model | Escherichia coli | 668369 | ||
Enterococcus faecium TX2465 | 1352 | |||
Escherichia coli TX1330 | 668369 | |||
Escherichia coli TX2046 | 668369 | |||
Escherichia coli TX2597 | 668369 | |||
Experiment for Molecule Alteration |
Southern blotting assay | |||
Experiment for Drug Resistance |
Twofold dilutions assay | |||
Mechanism Description | Disruption of msrC was associated with a two- to eightfold decrease in MICs of erythromycin azithromycin, tylosin, and quinupristin, suggesting that it may explain in part the apparent greater intrinsic resistance to macrolides of isolates of E. faecium relative to many streptococci. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.